1. Home
  2. KRRO vs RSF Comparison

KRRO vs RSF Comparison

Compare KRRO & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • RSF
  • Stock Information
  • Founded
  • KRRO 2014
  • RSF 2016
  • Country
  • KRRO United States
  • RSF United States
  • Employees
  • KRRO N/A
  • RSF N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • RSF Investment Managers
  • Sector
  • KRRO Health Care
  • RSF Finance
  • Exchange
  • KRRO Nasdaq
  • RSF Nasdaq
  • Market Cap
  • KRRO 58.6M
  • RSF 63.1M
  • IPO Year
  • KRRO 2019
  • RSF N/A
  • Fundamental
  • Price
  • KRRO $5.59
  • RSF $14.43
  • Analyst Decision
  • KRRO Buy
  • RSF
  • Analyst Count
  • KRRO 10
  • RSF 0
  • Target Price
  • KRRO $74.17
  • RSF N/A
  • AVG Volume (30 Days)
  • KRRO 1.0M
  • RSF 11.8K
  • Earning Date
  • KRRO 11-12-2025
  • RSF 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • RSF 10.61%
  • EPS Growth
  • KRRO N/A
  • RSF N/A
  • EPS
  • KRRO N/A
  • RSF N/A
  • Revenue
  • KRRO $7,371,000.00
  • RSF N/A
  • Revenue This Year
  • KRRO $116.91
  • RSF N/A
  • Revenue Next Year
  • KRRO N/A
  • RSF N/A
  • P/E Ratio
  • KRRO N/A
  • RSF N/A
  • Revenue Growth
  • KRRO N/A
  • RSF N/A
  • 52 Week Low
  • KRRO $5.42
  • RSF $14.81
  • 52 Week High
  • KRRO $56.69
  • RSF $16.23
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 21.22
  • RSF 44.74
  • Support Level
  • KRRO $5.42
  • RSF $14.23
  • Resistance Level
  • KRRO $6.59
  • RSF $14.48
  • Average True Range (ATR)
  • KRRO 1.20
  • RSF 0.15
  • MACD
  • KRRO -0.82
  • RSF -0.00
  • Stochastic Oscillator
  • KRRO 0.70
  • RSF 41.21

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

Share on Social Networks: